Study finds no increased risk of gynecological cancer with testosterone use after five years

Transmasculine and gender-diverse individuals who use testosterone are not at increased risk of gynecological cancer in the first years of hormone therapy. This is evident from large-scale research by Amsterdam UMC, which was published in eClinicalMedicine.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup